BioSpace News Archive

Storm Therapeutics Announces Publication in Nature on RNA Epigenetics by Founder Professor Tony Kouzarides

The study has found an unexpected new drug target for acute myeloid leukaemia that could open new avenues to develop effective treatments against this potentially lethal disease.

November 27, 2017

·

2 min read

Business

XTL Biopharma Reports Third Quarter 2017 Financial Results

XTL reported approximately $6,085 thousand in cash and cash equivalents as of September 30, 2017, an increase of $4,066 thousand since December 31, 2016.

November 27, 2017

·

12 min read

Drug Development

NYU Langone Health Release: Changes in Bacterial Mix Linked to Antibiotics Increase Risk for Inflammatory Bowel Disease

The study results center on the microbiome, the mix of bacterial species that live in our intestines and co-evolved with humans to play roles in digestion, metabolism, and immunity.

November 27, 2017

·

4 min read

Business

Stratasys Inks Deal to Bring Advanced 3D Printed Medical Modeling to Global Health Tech Leader Philips

The agreement includes virtually seamless interfacing and dedicated workflows across Philips IntelliSpace Portal 10 and Stratasys Direct Manufacturing’s parts-on-demand service.

November 27, 2017

·

5 min read

Drug Development

European Commission Approves Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union

The EC approval is based on data from three Phase III clinical studies. The VOYAGE 1 and 2 trials, which compared guselkumab with placebo and HUMIRA.

November 27, 2017

·

9 min read

Business

TSO3 Announces the Death of Mr. Jean Lamarre

Mr. Lamarre contributed sound and constructive counsel on TSO3’s Board of Directors, and while leading TSO3’s Human Resources Committee.

November 27, 2017

·

1 min read

Business

Inflection Biosciences and RCSI Enter Research Collaboration to Target Therapy-Resistant Breast Cancer

Inflection Biosciences and RCSI, today announced a research collaboration that aims to understand mechanisms of resistance to major breast cancer therapies and examine potential new treatments of Inflection Biosciences for patients with a cancer that does not respond effectively to existing therapies.

November 27, 2017

·

4 min read

Policy

Quidel Confident in Legal Strength and Validity of Supply Agreement With Beckman Coulter to Sell BNP Assay Assets

Quidel views Beckman’s claims as meritless, and in opposition to Beckman’s long-standing strategy of honoring the Supply Agreement with its previous partners.

November 27, 2017

·

4 min read

Business

Recipharm Equips a Further Three Facilities for U.S. Serialisation

The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialised products to the U.S. and take the total number of facilities able to offer serialisation capabilities to nine.

November 27, 2017

·

2 min read

Tiziana Life Sciences: Placing to Raise £275,000

Application has been made to the London Stock Exchange plc to admit the Placing Shares to trading on AIM and admission is expected to occur on 11 December 2017.

November 27, 2017

·

3 min read